Alzheimer’s Disease Drug Significantly Cuts Serious Psychiatric
Medical News Today - The Medical University of South Carolina (MUSC) announced today that results of a Phase 2 trial of an investigational drug for the treatment of Alzheimer’s disease, known as Flurizan , were presented today by Jacobo Mintzer, M.D., Professor in the
Memory loss can be attributed to factors other than Alzheimer s
Asheville Citizen-Times - Question: Recently, I have found myself forgetting people s names a lot. It is embarrassing. Does this mean I am getting Alzheimer s? Answer: As we get older, we sometimes worry that our memory is slipping. The big question is: When is this not
Simple Test May Predict Alzheimer’s Risk
KGO - July 17 - Alzheimer’s is a devastating illness affecting millions of Americans and their families. Now a new twist to a common and inexpensive test may tell relatives if they too will suffer from the mind-altering disease. Beth and her sister, Dianne
Blood Product Shows Promise in Treating Alzheimer s
New York Times - A blood product normally used to treat immune disorders and a type of leukemia may also slow or stop mental decline in people with Alzheimer s disease, researchers reported yesterday at an Alzheimer s conference in Madrid. The product is called
Grecian Festival starts today
Warren Tribune Chronicle - l Alzheimer s Support Group, 7 p.m., Ridge Crest Care Center, 1926 Ridge Ave., Warren. 330-369-4672 l Alzheimer s Family Support Group, 10 a.m., Easter Seal Day Center, 155 S. Park Ave., Warren. All meetings are free and open to the public. 330
Blood sugar problems linked to Alzheimer’s risk
WTHR - The nation’s obesity epidemic may be triggering another health outbreak: Alzheimer’s. New research suggests more than 40 million Americans who struggle with blood sugar, a common obesity side effect, may also be at risk of Alzheimer’s. Exercise can
DiaGenic ASA Presents Breakthrough Data on Development of the First
Genetic Engineering News - DiaGenic ASA (OSE:DIAG) today announced that it has achieved important milestones in the development of a diagnostic test for Alzheimer’s disease. New scientific data based on gene expression analysis confirms that the development of a simple blood
Promising immune therapy for Alzheimer’s
Newsday - Experimental immune therapy for Alzheimer’s has proven successful in ongoing studies of eight New Yorkers, six of whom improved over 18 months. “For some, it is quite remarkable,” said Dr. Norman Relkin, an associate professor of clinical neurology